CEO SUMMARY: Drugs-of-abuse (DOA) testing is an intensely-competitive market poised for significant change. Historically, national lab companies have been the major players and used rock-bottom prices to control the nationâs biggest corporate DOA clients. But since this line of testing yields meager profits at best, indications are that the nationâs two largest labs intend to […]
Quiet Changes To Ripple Drugs-of-Abuse Market
Evidence grows that two blood brothers are gradually de-emphasizing DOA testing
- By Robert Michel
- > From the Volume IX No. 17 - December 9, 2002 Issue
